Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1982 2
1983 1
1984 3
1985 1
1986 1
1987 4
1988 2
1991 1
1992 2
1993 4
1994 3
1995 2
1998 3
1999 2
2000 2
2001 1
2002 1
2003 2
2004 3
2006 1
2007 5
2008 5
2009 1
2010 2
2012 1
2013 2
2014 3
2015 2
2016 1
2019 1
2020 3
2021 4
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.
Gadelha M, Bex M, Feelders RA, Heaney AP, Auchus RJ, Gilis-Januszewska A, Witek P, Belaya Z, Yu Y, Liao Z, Ku CHC, Carvalho D, Roughton M, Wojna J, Pedroncelli AM, Snyder PJ. Gadelha M, et al. Among authors: bex m. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2882-e2895. doi: 10.1210/clinem/dgac178. J Clin Endocrinol Metab. 2022. PMID: 35325149 Free PMC article. Clinical Trial.
Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.
Feelders RA, Fleseriu M, Kadioglu P, Bex M, González-Devia D, Boguszewski CL, Yavuz DG, Patino H, Pedroncelli AM, Maamari R, Chattopadhyay A, Biller BMK, Pivonello R. Feelders RA, et al. Among authors: bex m. Front Endocrinol (Lausanne). 2023 Oct 9;14:1165681. doi: 10.3389/fendo.2023.1165681. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37876540 Free PMC article. Clinical Trial.
Giant prolactinomas in women.
Delgrange E, Raverot G, Bex M, Burman P, Decoudier B, Devuyst F, Feldt-Rasmussen U, Andersen M, Maiter D. Delgrange E, et al. Among authors: bex m. Eur J Endocrinol. 2013 Nov 22;170(1):31-8. doi: 10.1530/EJE-13-0503. Print 2014 Jan. Eur J Endocrinol. 2013. PMID: 24088550 Review.
Growth hormone and bone health.
Bex M, Bouillon R. Bex M, et al. Horm Res. 2003;60 Suppl 3:80-6. doi: 10.1159/000074507. Horm Res. 2003. PMID: 14671403 Review.
Exploring stem cell biology in pituitary tumors and derived organoids.
Nys C, Lee YL, Roose H, Mertens F, De Pauw E, Kobayashi H, Sciot R, Bex M, Versyck G, De Vleeschouwer S, Van Loon J, Laporte E, Vankelecom H. Nys C, et al. Among authors: bex m. Endocr Relat Cancer. 2022 Jun 17;29(7):427-450. doi: 10.1530/ERC-21-0374. Endocr Relat Cancer. 2022. PMID: 35521774
Retention of [(18)F]fluoride on reversed phase HPLC columns.
Ory D, Van den Brande J, de Groot T, Serdons K, Bex M, Declercq L, Cleeren F, Ooms M, Van Laere K, Verbruggen A, Bormans G. Ory D, et al. Among authors: bex m. J Pharm Biomed Anal. 2015;111:209-14. doi: 10.1016/j.jpba.2015.04.009. Epub 2015 Apr 9. J Pharm Biomed Anal. 2015. PMID: 25898315
74 results